BioNTech SE
Records under this name other than the patents BioNTech SE holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 119 patents it holds.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,617,321 | Tumor Vaccination Involving a Humoral Immune Response Against Self-Proteins now held by BioNTech Protein Therapeutics GmbH In force · High confidence | In force | High confidence | |
| US 10,526,387 | Tumor Vaccination Involving a Humoral Immune Response Against Self-Proteins now held by Tron - Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg-Universität Mainz Gemeinnützige GmbH - Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg-Universität Mainz Gemeinnützige GmbH In force · High confidence | In force | High confidence | |
| US 9,637,548 | Methods and Compositions for Diagnosis and Treatment of Cancer In force · High confidence | In force | High confidence | |
| US 10,717,780 | Agents for Treatment of Claudin Expressing Cancer Diseases now held by Astellas Pharma Inc. In force · High confidence | In force | High confidence | |
| US 12,642,844 | Individualized Vaccines for Cancer now held by BioNTech Rna Pharmaceuticals GmbH In force · High confidence | In force | High confidence | |
| US 9,586,997 | Antigen-Specific T Cell Receptors and T Cell Epitopes In force · High confidence | In force | High confidence | |
| US 10,093,736 | Agents for Treatment of Claudin Expressing Cancer Diseases now held by Astellas Pharma Inc. In force · High confidence | In force | High confidence | |
| US 10,188,712 | Tumor Antigens for Determining Cancer Therapy now held by Tron Ggmbh In force · High confidence | In force | High confidence | |
| US 10,604,568 | Diagnosis and Therapy of Cancer Involving Cancer Stem Cells now held by Astellas Pharma Inc. In force · High confidence | In force | High confidence | |
| US 10,550,430 | Method and Kit for Determining Whether a Subject Shows an Immune Response now held by BioNTech Diagnostics GmbH In force · High confidence | In force | High confidence |